Getting The Complete Picture on Drug Spend Trends
Last month, at the inaugural IngenioRx DiRxections conference, the first annual IngenioRx Total View Drug Trend Report was released. This report details the consolidated pharmacy + medical drug trends for Anthem’s affiliated health plans and provides a complete picture of drug trend, including the 21% of total drug spend paid under the medical benefit.
What this means
By taking a holistic approach and having a complete understanding of drug trends, management strategies can be refined rather than just shifting costs between the pharmacy and medical benefits. Instead, managing across the benefits puts members at the center of the solution and makes the complex simple – enhancing their experiences, helping to improve outcomes and drive down costs.
The numbers for 2017
- Total drug trend was 2% as a result of integrated strategies, which allowed a reduction in trend by 4%.
- Specialty drugs made up 50.2% of total drug spend, with 42% of specialty spend occurring under the medical benefit.
For more insights on 2017 drug spend and trend, take a look at the IngenioRx Total View Drug Trend Report.